BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 21294614)

  • 1. Spinal ependymomas in neurofibromatosis Type 2: a retrospective analysis of 55 patients.
    Plotkin SR; O'Donnell CC; Curry WT; Bove CM; MacCollin M; Nunes FP
    J Neurosurg Spine; 2011 Apr; 14(4):543-7. PubMed ID: 21294614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bevacizumab treatment for symptomatic spinal ependymomas in neurofibromatosis type 2.
    Farschtschi S; Merker VL; Wolf D; Schuhmann M; Blakeley J; Plotkin SR; Hagel C; Mautner VF
    Acta Neurol Scand; 2016 Jun; 133(6):475-80. PubMed ID: 26369495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The response of spinal cord ependymomas to bevacizumab in patients with neurofibromatosis Type 2.
    J Neurosurg Spine; 2017 Apr; 26(4):474-482. PubMed ID: 27982762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spinal ependymomas. Part 1: Intramedullary ependymomas.
    Klekamp J
    Neurosurg Focus; 2015 Aug; 39(2):E6. PubMed ID: 26235023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of spinal tumors in neurofibromatosis type 2 patients.
    Nowak A; Dziedzic T; Czernicki T; Kunert P; Marchel A
    Neurol Neurochir Pol; 2016; 50(1):31-5. PubMed ID: 26851687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurofibromatosis-2 and spinal cord ependymomas: Report of two cases and review of the literature.
    Aguilera DG; Mazewski C; Schniederjan MJ; Leong T; Boydston W; Macdonald TJ
    Childs Nerv Syst; 2011 May; 27(5):757-64. PubMed ID: 21132433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spinal ependymomas in NF2: a surgical disease?
    Kalamarides M; Essayed W; Lejeune JP; Aboukais R; Sterkers O; Bernardeschi D; Peyre M; Lloyd SK; Freeman S; Hammerbeck-Ward C; Kellett M; Rutherford SA; Evans DG; Pathmanaban O; King AT
    J Neurooncol; 2018 Feb; 136(3):605-611. PubMed ID: 29188529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spinal cord tanycytic ependymoma associated with neurofibromatosis type 2.
    Lim BS; Park SQ; Chang UK; Kim MS
    J Clin Neurosci; 2010 Jul; 17(7):922-4. PubMed ID: 20403699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ependymoma of the spinal cord in children and adolescents: a retrospective series from the HIT database.
    Benesch M; Weber-Mzell D; Gerber NU; von Hoff K; Deinlein F; Krauss J; Warmuth-Metz M; Kortmann RD; Pietsch T; Driever PH; Quehenberger F; Urban C; Rutkowski S
    J Neurosurg Pediatr; 2010 Aug; 6(2):137-44. PubMed ID: 20672934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosis by tumor location in adults with spinal ependymomas.
    Oh MC; Kim JM; Kaur G; Safaee M; Sun MZ; Singh A; Aranda D; Molinaro AM; Parsa AT
    J Neurosurg Spine; 2013 Mar; 18(3):226-35. PubMed ID: 23311515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spinal ependymomas. Part 2: Ependymomas of the filum terminale.
    Klekamp J
    Neurosurg Focus; 2015 Aug; 39(2):E7. PubMed ID: 26235024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis by tumor location for pediatric spinal cord ependymomas.
    Oh MC; Sayegh ET; Safaee M; Sun MZ; Kaur G; Kim JM; Aranda D; Molinaro AM; Gupta N; Parsa AT
    J Neurosurg Pediatr; 2013 Mar; 11(3):282-8. PubMed ID: 23259510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical presentation, immunohistochemistry and electron microscopy indicate neurofibromatosis type 2-associated gliomas to be spinal ependymomas.
    Hagel C; Stemmer-Rachamimov AO; Bornemann A; Schuhmann M; Nagel C; Huson S; Evans DG; Plotkin S; Matthies C; Kluwe L; Mautner VF
    Neuropathology; 2012 Dec; 32(6):611-6. PubMed ID: 22394059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple primary intramedullary ependymomas: a case report and review of the literature.
    Bydon M; Mathios D; Aguayo-Alvarez JJ; Ho C; Gokaslan ZL; Bydon A
    Spine J; 2013 Oct; 13(10):1379-86. PubMed ID: 23988460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth dynamics of intramedullary spinal tumors in patients with neurofibromatosis type 2.
    Lawson McLean AC; Rosahl SK
    Clin Neurol Neurosurg; 2016 Jul; 146():130-7. PubMed ID: 27208873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical strategies and outcomes of spinal ependymomas of different lengths: analysis of 210 patients: clinical article.
    Li TY; Chu JS; Xu YL; Yang J; Wang J; Huang YH; Kwan AL; Wang GH
    J Neurosurg Spine; 2014 Aug; 21(2):249-59. PubMed ID: 24836662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resection of myxopapillary ependymomas in children.
    Bagley CA; Kothbauer KF; Wilson S; Bookland MJ; Epstein FJ; Jallo GI
    J Neurosurg; 2007 Apr; 106(4 Suppl):261-7. PubMed ID: 17465358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple schwannomas: schwannomatosis or neurofibromatosis type 2?
    Seppälä MT; Sainio MA; Haltia MJ; Kinnunen JJ; Setälä KH; Jääskeläinen JE
    J Neurosurg; 1998 Jul; 89(1):36-41. PubMed ID: 9647170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular genetic analysis of ependymal tumors. NF2 mutations and chromosome 22q loss occur preferentially in intramedullary spinal ependymomas.
    Ebert C; von Haken M; Meyer-Puttlitz B; Wiestler OD; Reifenberger G; Pietsch T; von Deimling A
    Am J Pathol; 1999 Aug; 155(2):627-32. PubMed ID: 10433955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes in treatment for primary spinal anaplastic ependymomas: a retrospective series of 20 patients.
    Liu X; Sun B; Xu Q; Che X; Hu J; Gu S; Shou J
    J Neurosurg Spine; 2013 Jul; 19(1):3-11. PubMed ID: 23662884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.